(VIANEWS) – Shares of ONWARD MEDICAL (BEL 20: ONWD.BR) slid by a staggering 16.12% in 5 sessions from €6.08 to €5.10 at 20:22 EST on Wednesday, after four consecutive sessions in a row of losses. BEL 20 is rising 0.37% to €3,492.77, after five sequential sessions in a row of losses.
ONWARD MEDICAL’s last close was €5.34, 35.12% under its 52-week high of €8.23.
About ONWARD MEDICAL
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Earnings Per Share
As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.03.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.44%.
More news about ONWARD MEDICAL (ONWD.BR).
